Senior Vice President, General Counsel/Chief Compliance Officer
Ms. Joseph is a seasoned public company General Counsel, with broad global experience in the development and commercialization of products in various therapeutic areas. She previously served as Senior Vice President, General Counsel of Cubist Pharmaceuticals, Inc., where she was responsible for the law, compliance, risk management and government affairs departments. Prior to that, she served as Executive Vice President, General Counsel of Mayne Pharma Ltd., where she both prepared the company for listing on the London Stock Exchange and advised the Board regarding Mayne’s acquisition by Hospira, Inc. Before that she served at Transkaryotic Therapies, Inc. as Vice President, General Counsel during the negotiations with Shire Pharmaceuticals Group Plc and through that company’s acquisition by Shire. From 1998 to 2005, Ms. Joseph led the Biogen Idec legal department’s operations outside the United States as Vice President, International Legal. Ms. Joseph began her legal career as a litigator with Fried, Frank, Harris, Shriver & Jacobson in New York City and later at Morrison & Foerster in Los Angeles, New York, and Brussels. Ms. Joseph has an AB in Economics from Duke University, a J.D. from the University of Michigan Law School, an LLM degree in European Community Law from the College of Europe in Belgium, and an LLM degree in Civil Law from the University of Paris. She is a member of the bar in New York, California, England and Wales. Ms. Joseph is also an independent director and the incoming Vice Chair at Public Health Foundation Enterprises (PHFE), a non-profit public health organization. She currently serves as Vice Chair of PHFE’s Audit Committee and is a member of its Governance and Nominating Committee.